Myogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Meadows, Eric ^a,b   Flynn, Jesse M ^a,b   Klein, William H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MYOGENIN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXERCISE; GENE DELETION; GENE EXPRESSION REGULATION; GENE THERAPY; MOUSE; MUSCLE FATIGUE; MUSCLE METABOLISM; MUSCLE REGENERATION; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; RISK FACTOR; SKELETAL MUSCLE; TRANSGENE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; PHYSIOLOGY; REGENERATION; TRANSGENIC MOUSE;

MUS;

ANIMALS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYOGENIN; PHYSICAL CONDITIONING, ANIMAL; REGENERATION; TRANSGENES;

EID: 79251633567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016184     Document Type: Article

References (48)

1. Emery AE (1991) Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1: 19-29.
2. Hoffman EP, Brown RH, Jr., Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
3. Engel A, Franzini-Armstrong C (2004) Myology: basic and clinical. New York: McGraw-Hill, Medical Pub. Division. pp 2 v. (1960 p.).
4. Bulfield G, Siller WG, Wight PA, Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81: 1189-1192.
5. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, et al. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580.
6. Chamberlain JS, Pearlman JA, Muzny DM, Gibbs RA, Ranier JE, et al. (1988) Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 239: 1416-1418.
7. Dangain J, Vrbova G (1984) Muscle development in mdx mutant mice. Muscle Nerve 7: 700-704.
8. Tanabe Y, Esaki K, Nomura T (1986) Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 69: 91-95.
9. Head SI, Williams DA, Stephenson DG (1992) Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc Biol Sci 248: 163-169.
10. Carnwath JW, Shotton DM (1987) Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 80: 39-54.
11. De la Porte S, Morin S, Koenig J (1999) Characteristics of skeletal muscle in mdx mutant mice. Int Rev Cytol 191: 99-148.
12. Wehling-Henricks M, Oltmann M, Rinaldi C, Myung KH, Tidball JG (2009) Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 18: 3439-3451.
13. Schiaffino S, Sandri M, Murgia M (2007) Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 22: 269-278.
14. Hamilton MT, Booth FW (2000) Skeletal muscle adaptation to exercise: a century of progress. J Appl Physiol 88: 327-331.
15. Gladden LB (2008) A lactatic perspective on metabolism. Med Sci Sports Exerc 40: 477-485.
16. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, et al. (1993) Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
17. Knapp JR, Davie JK, Myer A, Meadows E, Olson EN, et al. (2006) Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development 133: 601-610.
18. Meadows E, Cho JH, Flynn JM, Klein WH (2008) Myogenin regulates a distinct genetic program in adult muscle stem cells. Dev Biol 322: 406-414.
19. Hughes SM, Chi MM, Lowry OH, Gundersen K (1999) Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J Cell Biol 145: 633-642.
20. Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ, et al. (1993) Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 118: 1137-1147.
21. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, et al. (2010) Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143: 35-45.
22. Flynn JM, Meadows E, Fiorotto M, Klein WH (2010) Myogenin Regulates Exercise Capacity and Skeletal Muscle Metabolism in the Adult Mouse. PLoS ONE 5: e13535.
23. Ciafaloni E, Moxley RT (2008) Treatment options for Duchenne muscular dystrophy. Curr Treat Options Neurol 10: 86-93.
24. Muir LA, Chamberlain JS (2009) Emerging strategies for cell and gene therapy of the muscular dystrophies. Expert Rev Mol Med 11: e18.
25. Beilharz MW, Lareu RR, Garrett KL, Grounds MD, Fletcher S (1992) Quantitation of muscle precursor cell activity in skeletal muscle by Northern analysis of MyoD and myogenin expression: Application to dystrophic (mdx) mouse muscle. Mol Cell Neurosci 3: 326-331.
26. Ohkawa Y, Yoshimura S, Higashi C, Marfella CG, Dacwag CS, et al. (2007) Myogenin and the SWI/SNF ATPase Brg1 maintain myogenic gene expression at different stages of skeletal myogenesis. J Biol Chem 282: 6564-6570.
27. Venuti JM, Morris JH, Vivian JL, Olson EN, Klein WH (1995) Myogenin is required for late but not early aspects of myogenesis during mouse development. J Cell Biol 128: 563-576.
28. Sabourin LA, Rudnicki MA (2000) The molecular regulation of myogenesis. Clin Genet 57: 16-25.
29. Anderson JE, Ovalle WK, Bressler BH (1987) Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec 219: 243-257.
30. Coulton GR, Morgan JE, Partridge TA, Sloper JC (1988) The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14: 53-70.
31. Jin Y, Murakami N, Saito Y, Goto Y, Koishi K, et al. (2000) Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol 99: 619-627.
32. Allen D, Westerblad H (2004) Physiology. Lactic acid-the latest performanceenhancing drug. Science 305: 1112-1113.
33. Allen DG, Lamb GD, Westerblad H (2008) Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 88: 287-332.
34. Pedersen TH, Nielsen OB, Lamb GD, Stephenson DG (2004) Intracellular acidosis enhances the excitability of working muscle. Science 305: 1144-1147.
35. Robergs RA, Ghiasvand F, Parker D (2004) Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 287: R502-R516.
36. Glesby MJ, Rosenmann E, Nylen EG, Wrogemann K (1988) Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve 11: 852-856.
37. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10: 1173-1183.
38. Booth FW, Thomason DB (1991) Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 71: 541-585.
39. Matsumura K, Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17: 2-15.
40. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, et al. (2000) Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 97: 13818-13823.
41. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, et al. (1998) Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophindeficient skeletal muscle. Proc Natl Acad Sci U S A 95: 15090-15095.
42. Zhu X, Heunks LM, Ennen L, Machiels HA, Van Der Heijden HF, et al. (2006) Nitric oxide modulates neuromuscular transmission during hypoxia in rat diaphragm. Muscle Nerve 33: 104-112.
43. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, et al. (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299: 896-899.
44. Lira VA, Soltow QA, Long JH, Betters JL, Sellman JE, et al. (2007) Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Am J Physiol Endocrinol Metab 293: E1062-1068.
45. Percival JM, Anderson KN, Gregorevic P, Chamberlain JS, Froehner SC (2008) Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One 3: e3387.
46. Hayashi S, McMahon AP (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244: 305-318.
47. Bulfield G, Moore EA, Kacser H (1978) Genetic variation in activity of the enzymes of glycolysis and gluconeogenesis between inbred strains of mice. Genetics 89: 551-561.
48. Hakimi P, Yang J, Casadesus G, Massillon D, Tolentino-Silva F, et al. (2007) Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J Biol Chem 282: 32844-32855.